Octapharma
Clinical trials sponsored by Octapharma, explained in plain language.
-
New hope for toddlers with rare bleeding disorder: wilate shows promise
Disease control CompletedThis study tested a medicine called wilate in 12 children under 6 years old with severe von Willebrand disease, a bleeding disorder. The goal was to see if regular doses of wilate could prevent bleeding episodes over a year. The study measured how many bleeds occurred and checked…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Can an antibody boost shield CLL patients from deadly infections?
Disease control CompletedThis study tested a medicine called Panzyga in 247 people with chronic lymphocytic leukemia (CLL) who also have low antibody levels. The goal was to see if regular infusions of Panzyga could prevent serious infections. Participants received either Panzyga or a placebo, and resear…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated May 26, 2026 08:16 UTC
-
New drug shows promise for kids with sudden OCD and tics?
Symptom relief CompletedThis study tested a medicine called Panzyga (an immunoglobulin) against a placebo in 71 children aged 6 to 17 with PANS/PANDAS, a condition causing sudden severe OCD and other symptoms. The main goal was to see if Panzyga reduced OCD symptoms more than placebo after 9 weeks. Rese…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Symptom relief
Last updated May 26, 2026 08:25 UTC